Coding for first infliximab infusion in patient with rheumatoid arthritis
Coding Corner Question: September
Coding for first infliximab infusion in patient with rheumatoid arthritis
EULAR 2014: Biosimilar Drug Production Raises Concerns
Rheumatology experts question biosimilars’ safety, efficacy given their complex production process
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
Malignant Atrophic Papulosis Is Challenging to Diagnose, Treat
Patient histories, clinician reports of condition also called Köhlmeier-Degos disease underscore need for integrated, multidisciplinary care
What’s New in Inflammatory Arthritis?
Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair
Fellow’s Forum Case Report: Takayasu’s Arteritis
How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease
Exploring Kawasaki Disease
New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- Next Page »